The genetic telemedicine services provider doubled its total funding to $46m in a round featuring Echo Health Ventures, GE, Illumina, Kaiser Permanente and Manatt, Phelps & Phillips.
Genome Medical, a US-based provider of telemedicine services focused on genetically-driven insights, has collected $23m in a series B round led by strategic investment vehicle Echo Health Ventures.
Echo Health Ventures is the investment partnership created by health services provider Cambia Health and Mosaic Health Solutions, a vehicle for of health insurance provider Blue Cross and Blue Shield of North Carolina.
The round featured GE Ventures, Illumina Ventures and Kaiser Permanente Ventures: respective corporate venturing units of industrial and power…
